Detection of antimicrobial resistance in <5 h in Neisseria gonorrhoeae isolates using flow cytometry—proof of concept for seven clinically relevant antimicrobials
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkae034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Sofia Somajo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biomedical Sciences, Linnaeus University, Kalmar, Sweden. Hauptthemen laut MEDLINE: Gonorrhea, Anti-Infective Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Department of Research and Development, Region Kronoberg.
Abstract (Originalsprache)
Introduction
Antimicrobial resistance in Neisseria gonorrhoeae compromises gonorrhoea treatment and rapid antimicrobial susceptibility testing (AST) would be valuable. We have developed a rapid and accurate flow cytometry method (FCM) for AST of gonococci.
Methods
The 2016 WHO gonococcal reference strains, and WHO Q, R and S (n = 17) were tested against seven clinically relevant antibiotics (ceftriaxone, cefixime, azithromycin, spectinomycin, ciprofloxacin, tetracycline and gentamicin). After 4.5 h incubation of inoculated broth, the fluorescent dye Syto™ 9 was added, followed by FCM analysis. After gating, the relative remaining population of gonococci, compared with unexposed growth control samples, was plotted against antimicrobial concentration, followed by non-linear curve regression analysis. Furthermore, the response at one single concentration/tested antibiotic was evaluated with the intention to use as a screening test for detection of resistant gonococci.
Results
A dose-dependent response was seen in susceptible isolates for all tested antimicrobials. There was a clear separation between susceptible/WT and resistant/non-WT isolates for ceftriaxone, cefixime, spectinomycin, ciprofloxacin and tetracycline. In contrast, for azithromycin, only high-level-resistant isolates were distinguished, while resistant isolates with MICs of 4 mg/L were indistinguishable from WT (MIC ≤ 1 mg/L) isolates. For gentamicin, all tested 17 isolates were WT and FCM analysis resulted in uniform dose–response curves. Using a single antibiotic concentration and a 50% remaining cell population cut-off, the overall sensitivity and specificity for resistance detection were 93% and 99%, respectively.
Conclusions
By providing results in <5 h for gonococcal isolates, FCM-based AST can become a rapid screening method for antimicrobial resistance or antimicrobial susceptibility in gonococci.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biomedical Sciences, Linnaeus University, Kalmar, Sweden.
- Department of Clinical Microbiology, Region Kronoberg, Växjö/Karlskrona, Sweden.
- Faculty of Medicine and Health, WHO Collaborating Centre for Gonorrhoea and Other STIs, Örebro University, Örebro, Sweden.
- Institute for Global Health, University College London, London, UK.
ORCID-Profile: Sofia Somajo, Oskar Ekelund
Förderung
- Department of Research and Development
- Region Kronoberg
Zitieren
APA
Somajo, S., Nilsson, F., Ekelund, O., & Unemo, M. (2024). Detection of antimicrobial resistance in. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae034
Vancouver
Somajo S, Nilsson F, Ekelund O, Unemo M. Detection of antimicrobial resistance in. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae034
BibTeX
@article{Somajo2024,
author = {Somajo, Sofia and Nilsson, Frida and Ekelund, Oskar and Unemo, Magnus},
title = {Detection of antimicrobial resistance in},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkae034}
}
EUVIMED